Manifesto on united airways diseases (UAD): an Interasma (global asthma association – GAA) document
暂无分享,去创建一个
L. Boulet | G. Canonica | J. Bernstein | K. Kowal | E. Heffler | N. Rosário | S. Mihaicuta | I. Ansotegui | C. Nunes | P. Steiropoulos | F. Braido | I. Baiardini | A. Bikov | L. Dubuske | P. Santus | A. Tiotiu | J. Correia-de-Sousa | A. Emelyanov | J. Ivancevich | G. G. Fogelbach | H. Chong-Neto | P. Novakova | M. Labor | D. Nedeva | Slviya Novakova | Tommaso Perazzo
[1] P. Kuna,et al. Upper‐airway dysbiosis related to frequent sweets consumption increases the risk of asthma in children with chronic rhinosinusitis , 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[2] G. Abecasis,et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium , 2020, Nature Communications.
[3] G. Canonica,et al. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) , 2020, The World Allergy Organization journal.
[4] Nanditha Venkatesan,et al. Role of Dupilumab in Approved Indications of COVID-19 Patient: an Efficacy-Based Nonsystematic Critical Analysis , 2020, SN Comprehensive Clinical Medicine.
[5] J. Petrosino,et al. Longitudinal Changes in Early Nasal Microbiota and the Risk of Childhood Asthma , 2020, Pediatrics.
[6] C. Benden,et al. Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis , 2020, Journal of Cystic Fibrosis.
[7] J. Zein,et al. SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry , 2020, EClinicalMedicine.
[8] A. Javer,et al. Subcutaneous Mepolizumab Injection: An Adjunctive Treatment for Recalcitrant Allergic Fungal Rhinosinusitis Patients With Asthma , 2020, American journal of rhinology & allergy.
[9] Yongxiang Wei,et al. Definition and characteristics of acute exacerbation in adult patients with chronic rhinosinusitis: a systematic review , 2020, Journal of Otolaryngology - Head & Neck Surgery.
[10] C. Micheletto,et al. “Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry” , 2020, Allergy.
[11] V. Backer,et al. Chronic rhinosinusitis in COPD: A prevalent but unrecognized comorbidity impacting health related quality of life. , 2020, Respiratory medicine.
[12] P. Nair,et al. Dupilumab, severe asthma airway responses, and SARS‐CoV‐2 serology , 2020, Allergy.
[13] A. Sedaghat,et al. Chronic rhinosinusitis disease burden is associated with asthma-related emergency department usage , 2020, European Archives of Oto-Rhino-Laryngology.
[14] N. Lombardo,et al. Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma , 2020, International journal of immunopathology and pharmacology.
[15] COVID‐19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments , 2020, Allergy.
[16] S. Iwano,et al. Bronchial wall thickening is associated with severity of chronic rhinosinusitis. , 2020, Respiratory medicine.
[17] W. Sewell,et al. Systemic medication requirement in post-surgical patients with eosinophilic chronic rhinosinusitis. , 2020, Rhinology.
[18] G. Passalacqua,et al. COVID‐19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey , 2020, Allergy.
[19] Chuan Qin,et al. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID‐19 , 2020, Allergy.
[20] S. Konno,et al. Preoperative Pulmonary Function Testing to Predict Recurrence of Chronic Rhinosinusitis With Nasal Polyps , 2020, Allergy & rhinology.
[21] Identifying Patients at Greatest Risk of Mortality due to COVID-19: A New England Perspective , 2020, The western journal of emergency medicine.
[22] G. Ciprandi,et al. Clinical Characterization of the Frequent Exacerbator Phenotype in Asthma , 2020, Journal of clinical medicine.
[23] Todor A Popov,et al. ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020) , 2020, Allergy.
[24] A. Peters,et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 , 2020, Journal of Allergy and Clinical Immunology.
[25] H. Choi,et al. Bidirectional association between asthma and chronic rhinosinusitis: Two longitudinal follow-up studies using a national sample cohort , 2020, Scientific Reports.
[26] C. Olveira,et al. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey , 2020, Respiratory Medicine.
[27] Matteo Bonini,et al. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice , 2020, Allergy.
[28] S. Hadjadj,et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study , 2020, Diabetologia.
[29] Jin-Min Yuan,et al. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis , 2020, International Journal of Public Health.
[30] P. Barranco,et al. Should we consider paranasal and chest computed tomography in severe asthma patients? , 2020, Respiratory medicine.
[31] E. Bleecker,et al. COVID-19, asthma, and biological therapies: What we need to know , 2020, World Allergy Organization Journal.
[32] C. Bachert,et al. Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement , 2020, World Allergy Organization Journal.
[33] C. Bachert,et al. Perspective: COVID-19, implications of nasal diseases and consequences for their management , 2020, Journal of Allergy and Clinical Immunology.
[34] D. Halpin,et al. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective , 2020, European Respiratory Journal.
[35] M. Mantero,et al. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry. , 2020, Respiratory medicine.
[36] A. Helvik,et al. Rhinosinusitis without nasal polyps in COPD , 2020, ERJ Open Research.
[37] Y. Hasegawa,et al. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial , 2020, American journal of respiratory and critical care medicine.
[38] Todor A Popov,et al. International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants , 2020, The World Allergy Organization journal.
[39] A. Athavale,et al. Nasal Airway Resistance and Latent Lower Airway Involvement in Allergic Rhinitis. , 2020, The Journal of the Association of Physicians of India.
[40] Wei Wang,et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.
[41] C. Akdis,et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.
[42] Jiaomei Liu,et al. The association between allergic rhinitis and sleep: A systematic review and meta-analysis of observational studies , 2020, PloS one.
[43] A. Kanda,et al. Reduced Local Response to Corticosteroids in Eosinophilic Chronic Rhinosinusitis with Asthma , 2020, Biomolecules.
[44] J. Rao,et al. Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine , 2020, Journal of drugs in dermatology : JDD.
[45] J. Bousquet,et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper , 2020, The World Allergy Organization journal.
[46] C. Akdis,et al. Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy: What Is New? , 2020, Immunology and allergy clinics of North America.
[47] C. Hopkins,et al. Biologics for chronic rhinosinusitis. , 2019, The Cochrane database of systematic reviews.
[48] Clinical Factors Associated with Acute Exacerbations of Chronic Rhinosinusitis. , 2017, The Journal of allergy and clinical immunology.
[49] R. Schlosser,et al. The Unified Airway: Rhinologic Disease and Respiratory Disorders , 2020 .
[50] J. Dalphin,et al. Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis : A Real-Life Study , 2020 .
[51] G. Weinstock,et al. The upper-airway microbiota and loss of asthma control among asthmatic children , 2019, Nature Communications.
[52] A. Peters,et al. Prevalence and characterization of chronic rhinosinusitis in patients with non‒cystic fibrosis bronchiectasis at a tertiary care center in the United States , 2019, International forum of allergy & rhinology.
[53] B. Lipworth,et al. Does unified allergic airway disease impact on lung function and type 2 biomarkers? , 2019, Allergy, Asthma & Clinical Immunology.
[54] C. Bachert,et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials , 2019, The Lancet.
[55] R. Mahmoud,et al. A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance® Exhalation Delivery System Versus Flonase® Nasal Spray and Flovent® HFA Inhalational Aerosol. , 2019, Clinical therapeutics.
[56] B. Takkouche,et al. History of allergic rhinitis and risk of asthma; a systematic review and meta-analysis☆ , 2019, The World Allergy Organization journal.
[57] K. Ohta,et al. Asthma exacerbations in patients with asthma and rhinitis: Factors associated with asthma exacerbation and its effect on QOL in patients with asthma and rhinitis. , 2019, Allergology international : official journal of the Japanese Society of Allergology.
[58] A. Sheikh,et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases , 2019, Clinical and Translational Allergy.
[59] Tangchun Wu,et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study , 2019, The Lancet.
[60] H. Lou,et al. Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps. , 2019, The Journal of allergy and clinical immunology.
[61] T. Hamamoto,et al. Nasal nitric oxide in the inferior turbinate surface decreases with intranasal steroids in allergic rhinitis: A prospective study. , 2019, Auris, nasus, larynx.
[62] M. Hew,et al. Prevalence and Clinical Implications of Chronic Rhinosinusitis in People with Bronchiectasis: A Systematic Review. , 2019, The journal of allergy and clinical immunology. In practice.
[63] J. Pilewski,et al. Clinical predictors of cystic fibrosis chronic rhinosinusitis severity , 2019, International forum of allergy & rhinology.
[64] A. Iloreta,et al. The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps. , 2019, American journal of otolaryngology.
[65] L. Thuler,et al. Obstructive sleep apnea in patients with chronic rhinosinusitis with nasal polyps: a cross-sectional study. , 2019, Sleep medicine.
[66] M. d’Ortho,et al. OSA treatment with CPAP: Randomized crossover study comparing tolerance and efficacy with and without humidification by ThermoSmart , 2019, The clinical respiratory journal.
[67] M. Uysal,et al. Prevalence of atopy and allergic rhinitis in patients with adult non-cystic fibrosis bronchiectasis , 2019, Turkish journal of medical sciences.
[68] S. Matta,et al. Distinct “Immunoallertypes” of Disease and High Frequencies of Sensitization in Non‐Cystic Fibrosis Bronchiectasis , 2019, American journal of respiratory and critical care medicine.
[69] A. Cox,et al. Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents , 2019, Front. Pharmacol..
[70] Jianbo Shi,et al. The effects of endoscopic sinus surgery on pulmonary function in chronic rhinosinusitis patients with asthma: a systematic review and meta-analysis , 2019, European Archives of Oto-Rhino-Laryngology.
[71] E. Bateman,et al. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps. , 2019, The journal of allergy and clinical immunology. In practice.
[72] C. Bachert,et al. Staphylococcus aureus Nasal Colonization and Asthma in Adults: Systematic Review and Meta-Analysis. , 2019, The journal of allergy and clinical immunology. In practice.
[73] Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms , 2019, Allergy, asthma & immunology research.
[74] C. Bachert,et al. Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis , 2019, Allergy.
[75] R. Sindwani,et al. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps , 2018, American journal of rhinology & allergy.
[76] P. Cullinan,et al. Are high‐ and low‐molecular‐weight sensitizing agents associated with different clinical phenotypes of occupational asthma? , 2018, Allergy.
[77] Ameet Singh,et al. Bioabsorbable steroid‐releasing implants in the frontal sinus ostia: a pooled analysis , 2018, International forum of allergy & rhinology.
[78] Onofrio Resta,et al. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[79] V. S. Sukhan. Allergic rhinitis and asthma co-morbidity. , 2019, Wiadomosci lekarskie.
[80] M. Sánchez-Borges,et al. Diagnosis of allergic sensitization in patients with allergic rhinitis and asthma in a tropical environment. , 2019, Revista alergia Mexico.
[81] J. Bernstein,et al. Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary Disease. , 2019, The journal of allergy and clinical immunology. In practice.
[82] D. Leopold,et al. NAVIGATE II: Randomized, double‐blind trial of the exhalation delivery system with fluticasone for nasal polyposis , 2019, The Journal of allergy and clinical immunology.
[83] B. Aggarwal,et al. Asia-Pacific Survey of Physicians on Asthma and Allergic Rhinitis (ASPAIR): physician beliefs and practices about diagnosis, assessment, and treatment of coexistent disease , 2018, Journal of asthma and allergy.
[84] Shuangquan Wu,et al. Association of allergic rhinitis with obstructive sleep apnea , 2018, Medicine.
[85] S. Mihaicuta,et al. Current opinions for the management of asthma associated with ear, nose and throat comorbidities , 2018, European Respiratory Review.
[86] L. Lynd,et al. Long-Term Trajectories of Mild Asthma in Adulthood and Risk Factors of Progression. , 2018, The journal of allergy and clinical immunology. In practice.
[87] Rosalind W. Picard,et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence , 2018, Clinical and Translational Allergy.
[88] A. Kanda,et al. HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study , 2018, Front. Immunol..
[89] Daniel Laune,et al. POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project , 2018, Clinical and Translational Allergy.
[90] L. Dubuske,et al. Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab. , 2018, Allergy and asthma proceedings.
[91] H. Chen,et al. Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis , 2018, International forum of allergy & rhinology.
[92] E. Bleecker,et al. Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma , 2018, European Respiratory Journal.
[93] J. Mullol,et al. Lack of long‐term add‐on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps , 2018, The Laryngoscope.
[94] D. Wang,et al. Precision medicine in united airways disease: A “treatable traits” approach , 2018, Allergy.
[95] R. Wood‐Baker,et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. , 2018, The Lancet. Respiratory medicine.
[96] V. Joish,et al. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma , 2018, The Journal of allergy and clinical immunology.
[97] I. Rengganis,et al. Comparison of Specific Immunoglobulin E with the Skin Prick Test in the Diagnosis of House Dust Mites and Cockroach Sensitization in Patients with Asthma and/or Allergic Rhinitis. , 2018, Acta medica Indonesiana.
[98] C. Leone,et al. Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis , 2018, International journal of chronic obstructive pulmonary disease.
[99] T. Keil,et al. What does lung function tell us about respiratory multimorbidity in childhood and early adulthood? Results from the MAS birth cohort study , 2018, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[100] C. Marquette,et al. The “one airway, one disease” concept in light of Th2 inflammation , 2018, European Respiratory Journal.
[101] S. Nguyen,et al. Systematic Review and Meta-analysis of SNOT-22 Outcomes after Surgery for Chronic Rhinosinusitis with Nasal Polyposis , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[102] Huabin Li,et al. Association of FcεRIβ polymorphisms with risk of asthma and allergic rhinitis: evidence based on 29 case–control studies , 2018, Bioscience reports.
[103] S. Rubino,et al. Fungi-Induced Upper and Lower Respiratory Tract Allergic Diseases: One Entity , 2018, Front. Microbiol..
[104] E. Lee,et al. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea , 2018, BMJ Open.
[105] T. Oguri,et al. Combined measurements of fractional exhaled nitric oxide and nasal nitric oxide levels for assessing upper airway diseases in asthmatic patients , 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.
[106] K. Lai,et al. The characteristic of asthma control among nasal diseases population: Results from a cross-sectional study , 2018, PloS one.
[107] Katrina L. Randall,et al. Antihistamines and allergy. , 2018, Australian prescriber.
[108] A. Sheikh,et al. 国际过敏与鼻科学共识声明 : 变应性鼻炎 , 2018 .
[109] R. Rosenfeld,et al. Endoscopic Sinus Surgery Improves Sleep Quality in Chronic Rhinosinusitis: A Systematic Review and Meta-analysis , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[110] A. Biffi,et al. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients. , 2018, European review for medical and pharmacological sciences.
[111] S. Steinshamn,et al. The Prevalence and Symptom Profile of Asthma–COPD Overlap: The HUNT Study , 2018, COPD.
[112] Yongxiang Wei,et al. Clinical Phenotypes of Nasal Polyps and Comorbid Asthma Based on Cluster Analysis of Disease History. , 2017, The journal of allergy and clinical immunology. In practice.
[113] M. Strek,et al. Asthma Outcomes and Management During Pregnancy , 2017, Chest.
[114] J. Bousquet,et al. Non‐allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology , 2017, Allergy.
[115] Katherine A. Kelly,et al. Evaluating the sinus and Nasal Quality of Life Survey in the pediatric cystic fibrosis patient population. , 2017, International journal of pediatric otorhinolaryngology.
[116] Geng Xu,et al. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[117] Jonathan Liang,et al. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis , 2017, The Annals of otology, rhinology, and laryngology.
[118] S. Steinshamn,et al. The prevalence and symptom profile of asthma-COPD overlap: The HUNT Study , 2017 .
[119] W. Janssens,et al. Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD , 2017, International journal of chronic obstructive pulmonary disease.
[120] M. Krajinovic,et al. Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice , 2017, European Respiratory Journal.
[121] P. Demoly,et al. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control , 2017, Allergy.
[122] C. Bachert,et al. Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps. , 2017, Rhinology.
[123] A. Sheikh,et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta‐analysis , 2017, Allergy.
[124] J. Montserrat,et al. Effects of CPAP in patients with obstructive apnoea: is the presence of allergic rhinitis relevant? , 2017, Sleep and Breathing.
[125] T. Craig,et al. Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma , 2017, Journal of asthma and allergy.
[126] S. Zaghi,et al. High incidence of posterior nasal cavity obstruction in obstructive sleep apnea patients , 2017, Sleep Science and Practice.
[127] V. Ramakrishnan,et al. Sleep quality outcomes after medical and surgical management of chronic rhinosinusitis , 2017, International forum of allergy & rhinology.
[128] R. Antonijoan,et al. Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers , 2017, Current medical research and opinion.
[129] S. Nguyen,et al. Prospective, multicenter evaluation of balloon sinus dilation for treatment of pediatric chronic rhinosinusitis , 2016, International forum of allergy & rhinology.
[130] T. Hirano,et al. Determinants of Incomplete Asthma Control in Patients with Allergic Rhinitis and Asthma. , 2017, The journal of allergy and clinical immunology. In practice.
[131] C. Meotti,et al. Sinonasal characteristics and quality of life by SNOT-22 in adult patients with cystic fibrosis , 2017, European Archives of Oto-Rhino-Laryngology.
[132] Todor A Popov,et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle , 2016, Clinical and Translational Allergy.
[133] J. Mainz,et al. Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial. , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[134] L. Schiöler,et al. New evidence of increased risk of rhinitis in subjects with COPD: a longitudinal population study , 2016, International journal of chronic obstructive pulmonary disease.
[135] M. Román-Rodríguez,et al. Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain) , 2016, The European journal of general practice.
[136] M. Fraczek,et al. Investigation of sinonasal anatomy via low-dose multidetector CT examination in chronic rhinosinusitis patients with higher risk for perioperative complications , 2016, European Archives of Oto-Rhino-Laryngology.
[137] E. Tham,et al. Aeroallergen sensitization and allergic disease phenotypes in Asia. , 2016, Asian Pacific journal of allergy and immunology.
[138] Fadoua Bardei,et al. [Skin sensitisation profiles to inhalant allergens for patients in Tétouan city (North West of Morocco)]. , 2016, Revue de pneumologie clinique.
[139] O. Niemelä,et al. A 12-year prognosis of adult-onset asthma: Seinäjoki Adult Asthma Study. , 2016, Respiratory medicine.
[140] C. Cingi,et al. High Sensitization to House-Dust Mites in Patients with Allergic Rhinitis in the Eastern Black Sea Region of Turkey: A Retrospective Study , 2016, American journal of rhinology & allergy.
[141] R. Simons,et al. Cognitive Performance Effects of Bilastine 20 mg During 6 Hours at 8000 ft Cabin Altitude. , 2016, Aerospace medicine and human performance.
[142] Y. Hwang,et al. Factors associated with exacerbation in mild- to-moderate COPD patients , 2016, International journal of chronic obstructive pulmonary disease.
[143] V. Lund,et al. Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations. , 2016, Rhinology.
[144] P. Giavina-Bianchi,et al. United airway disease: current perspectives , 2016, Journal of asthma and allergy.
[145] X. Qiu,et al. [Safety and efficacy of omalizumab for the treatment of allergic rhinitis:Meta-analysis of randomized clinical trials]. , 2016, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.
[146] D. Passali,et al. Mometasone furoate nasal spray: a systematic review , 2016, Multidisciplinary Respiratory Medicine.
[147] A. Siracusa,et al. Occupational rhinitis affects occupational asthma severity , 2016, Journal of occupational health.
[148] P. Hellings,et al. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression. , 2016, The Journal of allergy and clinical immunology.
[149] Ying Wang,et al. Effects of functional endoscopic sinus surgery on the treatment of bronchiectasis combined with chronic rhino-sinusitis , 2016, Acta oto-laryngologica.
[150] J. Mullol,et al. Nasal polyps in patients with asthma: prevalence, impact, and management challenges , 2016, Journal of asthma and allergy.
[151] R. Manes,et al. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery , 2016, International forum of allergy & rhinology.
[152] S. Nguyen,et al. Twenty‐two–item Sino‐Nasal Outcome Test in a control population: a cross‐sectional study and systematic review , 2016, International forum of allergy & rhinology.
[153] Q. Hamid,et al. Effects of Fluticasone Furoate on Clinical and Immunological Outcomes (IL-17) for Patients With Nasal Polyposis Naive to Steroid Treatment , 2016, The Annals of otology, rhinology, and laryngology.
[154] E. R. Sutherland,et al. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. , 2016, JAMA.
[155] T. Kündig,et al. Novel Delivery Routes for Allergy Immunotherapy: Intralymphatic, Epicutaneous, and Intradermal. , 2016, Immunology and allergy clinics of North America.
[156] M. Zitun. Sleep Disruption in Chronic Rhinosinusitis , 2016 .
[157] C. Bachert,et al. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease. , 2016, Cytokine.
[158] G. Ciprandi,et al. The impact of anxiety and depression on outpatients with asthma. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[159] J. Virchow,et al. House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies. , 2015, The journal of allergy and clinical immunology. In practice.
[160] H. Esmaeilzadeh,et al. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial. , 2015, Clinical immunology.
[161] O. Urban,et al. Patients with chronic rhinosinusitis and simultaneous bronchial asthma suffer from significant extraesophageal reflux , 2015, International forum of allergy & rhinology.
[162] P. Gibson,et al. Rhinitis in pregnant women with asthma is associated with poorer asthma control and quality of life , 2015, The Journal of asthma : official journal of the Association for the Care of Asthma.
[163] S. Fujieda,et al. Association and management of eosinophilic inflammation in upper and lower airways. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[164] P. Dalcin,et al. Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment , 2015, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.
[165] A. Konno. [One airway, one disease]. , 2014, Arerugi = [Allergy].
[166] J. Mainz,et al. Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trial. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[167] D. Caimmi,et al. Recent Developments in United Airways Disease , 2012, Allergy, asthma & immunology research.
[168] S. Berk,et al. The Frequency of Chronic Rhinosinusitis/Nasal Polyp in COPD and Its Effect on the Severity of COPD , 2011, COPD.
[169] M. Rottem. [Allergic rhinitis and its impact on asthma]. , 2010, Harefuah.
[170] M. Fasano. Combined airways: impact of upper airway on lower airway , 2010, Current opinion in otolaryngology & head and neck surgery.
[171] A. Maselli,et al. Rhinobronchial syndrome: pathogenesis and correlation with allergic rhinitis in children. , 2008, International journal of pediatric otorhinolaryngology.
[172] C. Kepley. New approaches to allergen immunotherapy , 2006, Current allergy and asthma reports.
[173] G. Piatti,et al. Effects of zafirlukast on bronchial asthma and allergic rhinitis. , 2003, Pharmacological research.
[174] R. Slavin,et al. Occupational rhinitis. , 1992, Immunology and allergy clinics of North America.
[175] L. Boulet,et al. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. , 2000, The Journal of allergy and clinical immunology.
[176] G. Canonica,et al. United airways disease: therapeutic aspects , 2000, Thorax.
[177] L. Boulet,et al. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[178] U SERAFINI,et al. [Bronchial asthma]. , 1950, Rassegna giuliana di medicina.